ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD15 Antibody [MMA] (Pacific Blue™) (A121709)

This product is discontinued

Anti-CD15 Antibody [MMA] (Pacific Blue™) (A121709) has been discontinued and is no longer available.

View all available products.

Name
Anti-CD15 Antibody [MMA] (Pacific Blue™)
Description
Mouse monoclonal [MMA] antibody to CD15 (Pacific Blue™).
Specificity
This antibody reacts with an extracellular epitope of CD15, a cell membrane 3-fucosyl-N-acetyllactosamine (3-FAL) strongly expressed on granulocytes, monocytes, macrophages, and mast cells. It is also present on Langerhans cells and some myeloid precursors cells. This antibody is a superior reagent for identifying Hodgkin´s lymphoma.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: This reagent is designed for analysis of human blood cells using 4µl reagent / 100µl of whole blood or 106 cells in a suspension.
Reactivity
Human
Immunogen
U937 histiocytic lymphoma cells.
Host
Mouse
Clonality
Monoclonal
Clone ID
MMA
Isotype
IgM
Conjugate

Pacific Blue™

Excitation: 410nm, Emission: 455nm

Purification
This antibody is conjugated with Pacific Blue™ under optimum conditions. The conjugate is purified by size-exclusion chromatography.
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 15mM Sodium Azide.
Storage
Store in the dark at 2-8°C. Do not freeze!
Synonyms
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase, Alpha-(1,3)-fucosyltransferase 4, EC:2.4.1.152, ELAM-1 ligand fucosyltransferase, ELFT, FCT3A, Fuc-TIV, Fucosyltransferase 4, Fucosyltransferase IV, FucT-IV, FUT4, Galactoside 3-L-fucosyltransferase
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Proteins predicted to interact with CD15

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.6% Relevancy Score
97.9% Relevancy Score
93.4% Relevancy Score
92.7% Relevancy Score
92.7% Relevancy Score
92.5% Relevancy Score
92.5% Relevancy Score
92% Relevancy Score